EBQ:PEAPETT Study: Difference between revisions
(Created page with "{{JC info | title= Pulseless electrical activity in pulmonary embolism treated with thrombolysis (from the “PEAPETT” study) | abbreviation= PEAPETT study | expansion= | pu...") |
|||
| Line 20: | Line 20: | ||
==Conclusion== | ==Conclusion== | ||
Rapid administration of 50mg of tPA is safe and effective in achieving ROSC in patients with PEA due to massive pulmonary embolism leading to increased survival and reduction of pulmonary artery pressures | |||
==Major Points== | ==Major Points== | ||
Revision as of 06:46, 16 May 2020
incomplete Journal Club Article
Sharifi M et al.. "Pulseless electrical activity in pulmonary embolism treated with
thrombolysis (from the “PEAPETT” study)". American Journal of Emergency Medicine. 2016. 34:1963-1967.PubMed Full text
Clinical Question
Does low dose tissue plasminogen activator (tPA) improve survival in patients with pulseless electrical activity and cardiopulmonary arrest due to confirmed pulmonary embolism?
Conclusion
Rapid administration of 50mg of tPA is safe and effective in achieving ROSC in patients with PEA due to massive pulmonary embolism leading to increased survival and reduction of pulmonary artery pressures